The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Preparing Immunocompromised Patients for Risks of Traveling Abroad

Preparing Immunocompromised Patients for Risks of Traveling Abroad

September 15, 2015 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Digital Storm/shutterstock.com

Image Credit: Digital Storm/shutterstock.com

Summer is a season for travel, so if your immunocompromised patients plan to journey to regions where there are outbreaks of infections, such as chikungunya, tuberculosis, typhoid, yellow fever or other diseases, communication and preparation may prevent serious health events.

You Might Also Like
  • Vaccinations for Immunocompromised Patients Are Shared Responsibility of Specialists, Primary Care Physicians
  • Study Associates Higher Risks with Total Joint Arthroplasty among Patients with Hepatitis C
  • Long-Term Benefits, Risks of Biologic Disease-Modifying Anti-Rheumatic Drugs in Patients with RA
Explore This Issue
September 2015
Also By This Author
  • Search for Infectious Triggers of Rheumatic Disease Could Yield Options to Block Process

“The world teems with disease-causing organisms, and almost every infection is more serious in the immunocompromised,” says Amesh A. Adalja, MD, FACP, FACEP, senior associate, Center for Health Security at the University of Pittsburgh Medical Center and School of Medicine in Pittsburgh.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Whether for leisure or business, patients with autoimmune-related rheumatic diseases, such as rheumatoid arthritis, may want or need to travel to regions where infection risks may be high. However, these patients may be at significantly elevated risk for infections. A 2002 study published in Arthritis & Rheumatism looked at retrospective data on RA patients from 1955 to 1994 and found that this population’s infection risk was 19.64/100 person-years vs. 12.87/100 person-years for the general, healthy population.1 Both the effects of their disease on their immune systems and immunosuppressant agents, such as methotrexate or anti-tumor necrosis factor biologic drugs, may put them at especial risk for viral, bacteria or fungal infections that could be life threatening.

Rheumatologists must work with their patients to assess the risks, suggest precautions or help prepare for illness related to travel abroad. “You can’t give live vaccines to people who are immunocompromised,” says Michael D. Lockshin, MD, director of the Barbara Volcker Center for Women and Rheumatic Disease at the Hospital for Special Surgery in New York. “If people want to go to the Amazon, you can’t give them the yellow fever vaccine. I might tell them to be careful and to use a lot of bug spray, but you can’t do much for this population” if they travel to risky regions.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Current Risks

Many destinations currently have outbreaks of infectious diseases that pose a risk for immunocompromised patients, says Dr. Adalja, who is a spokesman for the Infectious Diseases Society of America.

“The key risk for an immunocompromised traveler is that they may be exposed to an infectious disease that may be particularly severe because of their health status,” he says. “Tuberculosis is a risk throughout the world, dengue fever and chikungunya are particularly concerning because of their presence in the Caribbean, and many nations in Asia have a high prevalence of multi-drug resistant forms of bacteria that travelers can contract. Diarrheal diseases, yellow fever and malaria are also concerns in Africa and Asia.”

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions Tagged With: Clinical, Disease, outbreaks, patient care, rheumatologists, riskIssue: September 2015

You Might Also Like:
  • Vaccinations for Immunocompromised Patients Are Shared Responsibility of Specialists, Primary Care Physicians
  • Study Associates Higher Risks with Total Joint Arthroplasty among Patients with Hepatitis C
  • Long-Term Benefits, Risks of Biologic Disease-Modifying Anti-Rheumatic Drugs in Patients with RA
  • Immunizations in Immunocomprised Patients

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.